RDU NAACCR Talk - Topics In Pediatrics

Recorded On: 02/26/2024

Overview
Speaker(s)

Adolescent and Young Adult (AYA) Oncology: The insights gained from the Malignant Germ Cell International Consortium (MaGIC).

Dr. A. Lindsay Frazier, MD

One of the most common adolescent and young adult (AYA) cancers are the cell tumors (GCTs), however no significant change has happened to GCTs treatments protocols in the last decades. The Malignant Germ Cell International Consortium (MaGIC) brings together the world’s leading experts in germ cell tumors (GCTs), from across the spectrum of cancer research, with the shared goal of developing more effective treatments for GCTs through scientific inquiry. As the lead of the Malignant Germ Cell Tumor International Consortium, Dr Lindsay will discuss AYA Oncology and share important lessons learned in the field of GCT research.

Forecasting for Accurate Procurement of Pediatric Chemotherapies.

Dr. Shrivastava, MD, MPH

Forecasting the cost and quantities of pediatric chemotherapies is an essential part of ensuring a reliable supply of essential medicines for the care of children with cancer. Dr. Shrivastava will describe the importance of access to accurate registry data and its relevance today amongst several critical drug shortages.

Dr. A Lindsay Frazier, MD, ScM

Professor of Pediatrics

Harvard Medical School

Dr. Frazier received her MD from Dartmouth Medical School in 1984, followed by a pediatric residency at Children’s Hospital Boston and a pediatric hematology-oncology fellowship at DFCI, where she joined the faculty in 1990. She received an ScM from Harvard School of Public Health in 1993. In clinical practice, she concentrates on germ cell tumors, while her epidemiologic research primarily focuses on colorectal cancer screening and prevention.

Dr. Nitin Shrivastava, MD, MPH

Pediatric Hematology /Oncology Fellow

Dana-Farber/Bostin Children's Cancer and Blood Disorders Center

Dr. Nitin Shrivastava is a pediatric hematology-oncology fellow in his final year of training at Dana-Farber Cancer Institute/Boston Children’s Hospital. He received his medical degree from the University of Massachusetts Medical School and completed a Master of Public Health at the Harvard T.H. Chan School of Public Health. He completed his residency in general pediatrics at Boston Children’s Hospital. In addition to his clinical work, Nitin has been focused on improving access to pediatric cancer care globally. During his fellowship, he has worked to improve forecasting the amounts and costs of chemotherapy forecasting for pediatric patients in the U.S., Canada, and internationally under the mentorship of Dr. Lindsay Frazier.